Lepäntalo M, Aromaa A, Klaukka T, Lukkari E
Acta Med Scand. 1985;218(1):35-9. doi: 10.1111/j.0954-6820.1985.tb08821.x.
Intermittent claudication has been claimed to be a side-effect of beta-adrenoceptor blocking drugs. The confounding effect of coronary heart disease has not been controlled in earlier studies. In this case-control study, the cases were selected from a hospital material of patients with verified intermittent claudication and the controls from a nationwide health survey. The pool of potential cases and controls consisted of persons who had been treated with antihypertensives, but did not have coronary heart disease. The controls and cases were matched for age, sex, place of residence and time of examination. Comparison of current or previous use of beta-blocking drugs among our 55 case-control pairs revealed no association between intermittent claudication and beta-blockade. beta-Blockade is not a risk factor for intermittent claudication.
间歇性跛行一直被认为是β-肾上腺素能受体阻滞剂的副作用。在早期研究中,冠心病的混杂效应并未得到控制。在这项病例对照研究中,病例选自一家医院确诊为间歇性跛行患者的资料,对照则选自一项全国性健康调查。潜在病例和对照的群体包括接受过抗高血压治疗但无冠心病的人。对照和病例在年龄、性别、居住地点和检查时间方面进行了匹配。对我们的55对病例对照进行当前或既往β受体阻滞剂使用情况的比较,结果显示间歇性跛行与β受体阻滞剂之间无关联。β受体阻滞剂不是间歇性跛行的危险因素。